BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2650235)

  • 21. Molecular genetic basis for the antiidiotypic antibody response associated with successful renal allograft survival in humans.
    Singal DP; Leber B; Harnish DG; Frame B; Joseph S; Blajchman MA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1059-61. PubMed ID: 1824885
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST).
    al-Muzairai IA; MacLeod AM; Cochrane S; Jones MC; Propper D; Catto GR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):748-9. PubMed ID: 2650254
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiotypic-antiidiotypic interactions in humans.
    Geha RS
    J Biol Response Mod; 1984 Dec; 3(6):573-9. PubMed ID: 6210347
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of anti-idiotypic antibodies to HLA antigens in human hepatic allograft tolerance.
    Mohanakumar T; Hoover SK; Rhodes C; Mendez-Picon G; Flye MW; Lee HM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2437-9. PubMed ID: 3079084
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunological selection of donors and recipients in renal grafts: antibodies].
    Seignalet J; Mourad G; Mion C
    Nephrologie; 1984; 5(1):33-9. PubMed ID: 6374486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-IgM antibodies may regulate the humoral response to paternal HLA antigens in pregnant women.
    Jakobisiak M; Singh B; Saidman S; Schlaut J; Dossetor JB
    Clin Invest Med; 1984; 7(2):123-5. PubMed ID: 6331935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of lymphocytotoxic activity in highly sensitised patients by anti-idiotypic antibodies.
    MacLeod AM; al-Muzairai IA; Innes A; Power DA; Stewart KN; Catto GR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):756-7. PubMed ID: 2650258
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmunity and self-antigens.
    Suciu-Foca N; King DW; Reemtsma K; Muller S; Kohler H
    Concepts Immunopathol; 1985; 1():173-89. PubMed ID: 3916402
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of antiidiotypic antibody with successful second transplant of a kidney sharing HLA antigens with the previous hyperacutely rejected first kidney.
    Rodey GE; Phelan DL
    Transplantation; 1989 Jul; 48(1):54-7. PubMed ID: 2665236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection and identification of anti-idiotypic antibodies in heterogeneous immunoenzyme analysis].
    Etkin AF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):63-7. PubMed ID: 3529755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplant-induced donor-specific antibodies and graft outcome.
    Martin S; Dyer PA; Mallick NP; Gokal R; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):899-90. PubMed ID: 3274886
    [No Abstract]   [Full Text] [Related]  

  • 33. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
    Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
    Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of rat renal allografts with idiotypic and antiidiotypic monoclonal alloantibodies.
    Stuart FP; Fitch FW; McKearn TJ
    Transplant Proc; 1982 Jun; 14(2):313-5. PubMed ID: 7051473
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of donor specific blood transfusions in prolongation of kidney graft survival.
    Matsumoto T; Sakagami K; Orita K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2264-7. PubMed ID: 2950636
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful transplantation in highly sensitized patients.
    Backman U; Fellström B; Frödin L; Sjöberg O; Tufveson G; Wikström B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):762-3. PubMed ID: 2650261
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-HLA antibodies: detection and effect on renal transplant function.
    Koka P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):243-4. PubMed ID: 8438286
    [No Abstract]   [Full Text] [Related]  

  • 38. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two major serologic events in a successful cardiac transplant recipient--circumvention of hyperacute rejection despite a positive donor T lymphocyte crossmatch and late appearance of probable antiidiotypic antibody.
    Braun WE; Klingman L; Stewart RW; Ratliff N; Tubbs R; Zachary AA; Teresi GA; Rincon G; Protiva D
    Transplantation; 1988 Jul; 46(1):153-5. PubMed ID: 3293276
    [No Abstract]   [Full Text] [Related]  

  • 40. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
    Dragun D
    Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.